These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 7922219
1. Mechanisms and treatment of dyslipidemia of renal diseases. Toto RD, Vega GL, Grundy SM. Curr Opin Nephrol Hypertens; 1993 Sep; 2(5):784-90. PubMed ID: 7922219 [Abstract] [Full Text] [Related]
2. [Dyslipidemias in renal diseases: pathogenesis and treatment]. Cuevas A, Maíz A, Arteaga A. Rev Med Chil; 1998 Mar; 126(3):315-21. PubMed ID: 9674303 [Abstract] [Full Text] [Related]
3. [Dyslipidemias and nephropathies]. Mioli V, Pacchiarotti P, Lombardo L, De Vizia L, Perilli A, Sprovieri G, Recchioni A, Marchesi V. Minerva Med; 1975 Oct 06; 66(66):3449-53. PubMed ID: 1178135 [No Abstract] [Full Text] [Related]
4. Management of hyperlipidemia of kidney disease. Grundy SM. Kidney Int; 1990 Mar 06; 37(3):847-53. PubMed ID: 2179614 [No Abstract] [Full Text] [Related]
5. Fluvastatin in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation. Corsini A, Holdaas H. Ren Fail; 2005 Mar 06; 27(3):259-73. PubMed ID: 15957541 [Abstract] [Full Text] [Related]
6. Dyslipidemia and its management after renal transplantation. Andany MA, Kasiske BL. J Nephrol; 2001 Mar 06; 14 Suppl 4():S81-8. PubMed ID: 11798152 [Abstract] [Full Text] [Related]
7. Lipid disorders and cardiovascular risks in nephrology. Dairou F. Nephrol Dial Transplant; 1998 Mar 06; 13 Suppl 4():30-3. PubMed ID: 9614662 [No Abstract] [Full Text] [Related]
8. Hypertriglyceridemia in chronic nonnephrotic renal failure. Gutman RA, Shalhoub RJ, Wade AD, O'Connell JM, Recant L. Am J Clin Nutr; 1973 Feb 06; 26(2):165-72. PubMed ID: 4574031 [No Abstract] [Full Text] [Related]
9. Disorders of blood-lipids in renal disease. Cramp DG, Moorhead JF, Wills MR. Lancet; 1975 Mar 22; 1(7908):672-3. PubMed ID: 47091 [Abstract] [Full Text] [Related]
17. Dyslipidemia after renal transplantation: a cause for concern? Butani L. Pediatr Transplant; 2008 Nov 28; 12(7):724-8. PubMed ID: 18444948 [No Abstract] [Full Text] [Related]
18. Lipid abnormalities in the nephrotic syndrome: the therapeutic role of statins. Wheeler DC. J Nephrol; 2001 Nov 28; 14 Suppl 4():S70-5. PubMed ID: 11798150 [Abstract] [Full Text] [Related]
19. [Treatments for dyslipidemia associated with kidney disease]. Hirano T, Yoshino G. Nihon Rinsho; 2001 Mar 28; 59 Suppl 3():748-52. PubMed ID: 11347167 [No Abstract] [Full Text] [Related]
20. Should hyperlipidemia in children with the nephrotic syndrome be treated? Querfeld U. Pediatr Nephrol; 1999 Jan 28; 13(1):77-84. PubMed ID: 10100296 [Abstract] [Full Text] [Related] Page: [Next] [New Search]